Integral Ad Science (NASDAQ:IAS) Price Target Raised to $13.50 at Morgan Stanley

Integral Ad Science (NASDAQ:IAS) had its target price hoisted by Morgan Stanley from $13.00 to $13.50 in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other equities research analysts have also recently commented on the company. Scotiabank assumed coverage on Integral Ad Science in a report on Friday. They set a “sector perform” rating and a $12.00 price target on the stock. Truist Financial boosted their target price on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a “buy” rating in a report on Monday. Piper Sandler lowered their price target on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a research report on Wednesday, November 13th. Benchmark restated a “hold” rating on shares of Integral Ad Science in a research report on Friday. Finally, Oppenheimer reaffirmed an “outperform” rating on shares of Integral Ad Science in a research note on Friday. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $15.06.

Integral Ad Science Stock Up 1.9 %

Shares of NASDAQ:IAS opened at $10.72 on Monday. Integral Ad Science has a 12-month low of $7.98 and a 12-month high of $13.62. The stock has a fifty day simple moving average of $10.34 and a two-hundred day simple moving average of $10.82. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of 53.60, a PEG ratio of 1.06 and a beta of 1.46. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). The company had revenue of $153.00 million for the quarter, compared to analysts’ expectations of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.06 earnings per share. On average, research analysts anticipate that Integral Ad Science will post 0.26 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Lisa Utzschneider sold 12,448 shares of the stock in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $10.61, for a total value of $132,073.28. Following the completion of the transaction, the chief executive officer now directly owns 278,650 shares in the company, valued at approximately $2,956,476.50. This represents a 4.28 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold a total of 19,109 shares of company stock valued at $197,696 in the last 90 days. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Alyeska Investment Group L.P. acquired a new stake in shares of Integral Ad Science during the fourth quarter valued at about $41,543,000. Dimensional Fund Advisors LP boosted its position in shares of Integral Ad Science by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company’s stock worth $39,567,000 after purchasing an additional 580,323 shares during the period. Clearline Capital LP acquired a new stake in Integral Ad Science in the 4th quarter valued at approximately $3,949,000. Invenomic Capital Management LP raised its position in Integral Ad Science by 52.9% in the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company’s stock valued at $9,344,000 after purchasing an additional 309,752 shares during the period. Finally, Ararat Capital Management LP boosted its position in shares of Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company’s stock worth $23,823,000 after buying an additional 269,346 shares during the period. 95.78% of the stock is owned by institutional investors and hedge funds.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.